Is it Time to Start Using Mitochondrial DNA Copy Number as an Indicator of Health and Diseases

Authors

  • Vasudeva G. Kamath Department of Biochemistry and Medical Genetics, Touro College of Osteopathic Medicine, Middletown, NY 10940, USA

DOI:

https://doi.org/10.17140/CSMMOJ-3-118

Abstract

Clinical biochemistry and pathology have contributed too many assays for diagnosis and prognosis of human health and diseases. Bedside biochemistry has revolutionized modern medicine and the invention of new generation biosensors have educated the patients like never before. Although, there are many gadgets which are available for monitoring the blood glucose in the patients with metabolic syndromes, hardly any assays can accurately predict and aid in early detection of metabolic syndrome. By the time a person is diagnosed and treated for metabolic syndrome, molecular and pathological damages further push the patient towards the metabolic syndrome. Early detection and early treatments are necessary to further revolutionize the field of Medicine.

References

Reznik E, Miller ML, Şenbabaoğlu Y, et al. Mitochondrial DNA copy number variation across human cancers. eLife. 2016; 5: e10769. doi: 10.7554/eLife.10769 Cancer Stud Mol Med Open J Page 22

Downloads

Published

2017-05-25

How to Cite

Vasudeva G. Kamath. (2017). Is it Time to Start Using Mitochondrial DNA Copy Number as an Indicator of Health and Diseases. Cancer Studies and Molecular Medicine , 3(2), 21–22. https://doi.org/10.17140/CSMMOJ-3-118

Issue

Vol. 3 No. 2 (2017): Volume 3 Issue 2 2017

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Cancer Studies and Molecular Medicine (CSMM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.